# Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

- Company: M.D. Anderson Cancer Center
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT01371630

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.